Mu‐Kuan Chen

7.8k total citations
169 papers, 4.0k citations indexed

About

Mu‐Kuan Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mu‐Kuan Chen has authored 169 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 40 papers in Oncology and 40 papers in Cancer Research. Recurrent topics in Mu‐Kuan Chen's work include Head and Neck Cancer Studies (35 papers), Head and Neck Surgical Oncology (20 papers) and Protease and Inhibitor Mechanisms (17 papers). Mu‐Kuan Chen is often cited by papers focused on Head and Neck Cancer Studies (35 papers), Head and Neck Surgical Oncology (20 papers) and Protease and Inhibitor Mechanisms (17 papers). Mu‐Kuan Chen collaborates with scholars based in Taiwan, United States and Russia. Mu‐Kuan Chen's co-authors include Shun‐Fa Yang, Ming‐Ju Hsieh, Chiao‐Wen Lin, Yu‐Sheng Lo, Yi‐Ching Chuang, Hui‐Ling Chiou, Chia‐Chieh Lin, Su‐Yu Chien, Jen‐Tsun Lin and Wei‐En Yang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer.

In The Last Decade

Mu‐Kuan Chen

165 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mu‐Kuan Chen 1.9k 855 778 654 631 169 4.0k
Chiao‐Wen Lin 2.7k 1.4× 1.4k 1.6× 905 1.2× 111 0.2× 176 0.3× 176 4.4k
Ying Liang 2.3k 1.2× 1.1k 1.3× 1.2k 1.5× 95 0.1× 384 0.6× 170 4.1k
Da‐Tian Bau 2.1k 1.1× 921 1.1× 691 0.9× 74 0.1× 224 0.4× 163 3.6k
Wenjie Guo 2.2k 1.2× 529 0.6× 839 1.1× 164 0.3× 469 0.7× 142 4.5k
Xiaoxin Chen 1.5k 0.8× 325 0.4× 436 0.6× 55 0.1× 973 1.5× 127 3.5k
Shigeki Nakagawa 1.7k 0.9× 994 1.2× 1.8k 2.4× 42 0.1× 1.2k 1.9× 184 4.9k
H S Garewal 851 0.5× 192 0.2× 1.2k 1.5× 93 0.1× 1.3k 2.1× 56 3.5k
Jiunn‐Liang Ko 2.3k 1.2× 648 0.8× 815 1.0× 47 0.1× 207 0.3× 184 4.7k
Hui‐Ling Chiou 1.9k 1.0× 701 0.8× 598 0.8× 40 0.1× 196 0.3× 94 3.8k
Shoichi Hazama 1.7k 0.9× 725 0.8× 2.1k 2.8× 44 0.1× 668 1.1× 187 4.5k

Countries citing papers authored by Mu‐Kuan Chen

Since Specialization
Citations

This map shows the geographic impact of Mu‐Kuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu‐Kuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu‐Kuan Chen more than expected).

Fields of papers citing papers by Mu‐Kuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu‐Kuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu‐Kuan Chen. The network helps show where Mu‐Kuan Chen may publish in the future.

Co-authorship network of co-authors of Mu‐Kuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mu‐Kuan Chen. A scholar is included among the top collaborators of Mu‐Kuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu‐Kuan Chen. Mu‐Kuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ho, Hsin‐Yu, et al.. (2024). Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells. Expert Opinion on Therapeutic Targets. 28(5). 461–471. 4 indexed citations
3.
Hsieh, Ming‐Ju, Chia‐Chieh Lin, Hsin‐Yu Ho, et al.. (2024). Pyrocurzerenone suppresses human oral cancer cell metastasis by inhibiting the expression of ERK1/2 and cathepsin S proteins. Journal of Cellular and Molecular Medicine. 28(16). e70015–e70015. 2 indexed citations
4.
Hsieh, Ming‐Ju, Jen‐Tsun Lin, Yi‐Ching Chuang, et al.. (2024). Raddeanin A augments the cytotoxicity of natural killer cells against chronic myeloid leukaemia cells by modulating MAPK and Ras/Raf signalling pathways. Journal of Cellular and Molecular Medicine. 28(16). e70016–e70016. 2 indexed citations
5.
Hsieh, Ming‐Ju, Jen‐Tsun Lin, Yi‐Ching Chuang, et al.. (2023). Limocitrin increases cytotoxicity of KHYG‐1 cells against K562 cells by modulating MAPK pathway. Environmental Toxicology. 38(12). 2939–2951. 1 indexed citations
6.
Hsieh, Ming‐Ju, Ming‐Ju Hsieh, Hsin‐Yu Ho, et al.. (2023). Semilicoisoflavone B Induces Apoptosis of Oral Cancer Cells by Inducing ROS Production and Downregulating MAPK and Ras/Raf/MEK Signaling. International Journal of Molecular Sciences. 24(5). 4505–4505. 10 indexed citations
8.
Yang, Cheng‐I, et al.. (2023). Exploring return to work for patients with head and neck cancer. Work. 77(1). 231–241. 1 indexed citations
9.
Yang, Wei‐En, Yi‐Tzu Chen, Chun‐Wen Su, et al.. (2023). Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK/HO‐1 pathway activation. Journal of Cellular and Molecular Medicine. 27(9). 1250–1260. 11 indexed citations
10.
Chen, Mu‐Kuan, et al.. (2022). Relationship between Preoperative Nutritional Status and Clinical Outcomes in Patients with Head and Neck Cancer. Nutrients. 14(24). 5331–5331. 6 indexed citations
11.
Ho, Hsin‐Yu, et al.. (2022). Narciclasine suppresses oral cancer metastasis by modulating cathepsin B and extracellular signal–related kinase pathways. Biomedicine & Pharmacotherapy. 158. 114159–114159. 8 indexed citations
12.
Chen, Mu‐Kuan, et al.. (2021). An LRFM Model to Analyze Outpatient Loyalty From a Medical Center in Taiwan. SAGE Open. 11(3). 2 indexed citations
13.
Chen, Mu‐Kuan, et al.. (2021). An Empirical Study of Hospital’s Outpatient Loyalty From a Medical Center in Taiwan. SAGE Open. 11(2). 2 indexed citations
14.
Hsieh, Ming‐Hong, Hsueh‐Ju Lu, Chiao‐Wen Lin, et al.. (2021). Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer. Journal of Personalized Medicine. 11(5). 348–348. 13 indexed citations
15.
Chung, Hsiao‐Hang, Mu‐Kuan Chen, Yu‐Chao Chang, et al.. (2017). Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells. Environmental Toxicology. 32(6). 1765–1774. 20 indexed citations
16.
Chuang, Shu‐Lin, Sam Li‐Sheng Chen, Amy Ming‐Fang Yen, et al.. (2017). Population‐based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers. Cancer. 123(9). 1597–1609. 122 indexed citations
17.
Su, Chun‐Wen, et al.. (2016). Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression. International Journal of Medical Sciences. 14(1). 37–44. 26 indexed citations
18.
Chen, Sung‐Lang, Wen‐Wei Sung, Ming‐Ju Hsieh, et al.. (2016). PBK/TOPK Expression Predicts Prognosis in Oral Cancer. International Journal of Molecular Sciences. 17(7). 1007–1007. 32 indexed citations
19.
Lin, Chiao‐Wen, Ying‐Erh Chou, Hui‐Ling Chiou, et al.. (2014). Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression. Expert Opinion on Therapeutic Targets. 18(10). 1109–1120. 45 indexed citations
20.
Liu, Mu-Tai, et al.. (2008). Clinical Features and Management of Distant Metastases from Nasopharyngeal Carcinoma. 15(2). 109–117. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026